Wolfgang Rathmann
Hat mitgewirkt an:
-
Cardiovascular disease prevalence in type 2 diabetes – an analysis of a large German statutory health insurance database
-
Pharmacogenetics of novel glucose-lowering drugs
-
The association between patient-reported self-management behavior, intermediate clinical outcomes, and mortality in patients with type 2 diabetes: results from the KORA-A study
-
Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA survey F3 (Augsburg, Germany)